DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,332 | +0.1% | 3,251 | +10.8% | 0.00% | – |
| Q2 2023 | $41,289 | -2.3% | 2,934 | +7.2% | 0.00% | – |
| Q1 2023 | $42,271 | -40.6% | 2,737 | -36.8% | 0.00% | – |
| Q4 2022 | $71,147 | +58.1% | 4,331 | +78.0% | 0.00% | – |
| Q3 2022 | $45,000 | +50.0% | 2,433 | +4.3% | 0.00% | – |
| Q2 2022 | $30,000 | +36.4% | 2,333 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | 0.0% | 2,333 | +2.5% | 0.00% | – |
| Q4 2021 | $22,000 | -87.0% | 2,275 | -54.2% | 0.00% | – |
| Q3 2021 | $169,000 | +4.3% | 4,965 | +12.0% | 0.00% | – |
| Q2 2021 | $162,000 | +7.3% | 4,433 | +31.7% | 0.00% | – |
| Q1 2021 | $151,000 | +371.9% | 3,365 | +517.4% | 0.00% | – |
| Q4 2020 | $32,000 | +10.3% | 545 | 0.0% | 0.00% | – |
| Q3 2020 | $29,000 | +314.3% | 545 | +369.8% | 0.00% | – |
| Q2 2020 | $7,000 | -70.8% | 116 | -83.4% | 0.00% | – |
| Q1 2020 | $24,000 | – | 698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $18,687,872 | 15.44% |
| Redmile Group, LLC | 5,582,105 | $86,243,522 | 3.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,218,638 | $80,627,957 | 1.80% |
| BRAIDWELL LP | 3,241,351 | $50,078,873 | 1.65% |
| Parkman Healthcare Partners LLC | 491,772 | $7,597,877 | 1.65% |
| Sunesis Advisors, LLC | 96,299 | $1,487,820 | 1.07% |
| ARMISTICE CAPITAL, LLC | 4,100,000 | $63,345,000 | 0.91% |
| Deep Track Capital, LP | 1,363,201 | $21,061,455 | 0.86% |
| AlphaCentric Advisors LLC | 72,500 | $1,120,125 | 0.77% |
| Ikarian Capital, LLC | 174,510 | $2,696,179 | 0.61% |